• Thurs news: GSK inks 2nd neuro pact in weeks. Teva episodic migraine trial. FDA clears AZ’s Imfinzi for aggressive lung cancer. Novartis fails to block generic Entresto. Nuvig gets immune drug funding. See more on our front page

GlaxoSmithKline

Anonymous board for GlaxoSmithKline
Replies
26
Views
3K
anonymous
Replies
10
Views
2K
anonymous
Replies
39
Views
7K
anonymous
Replies
43
Views
7K
anonymous
Replies
32
Views
10K
anonymous
Replies
130
Views
18K
anonymous
Replies
23
Views
3K
anonymous
Replies
9
Views
1K
anonymous
RFK
Replies
71
Views
3K
anonymous
Replies
3
Views
712
anonymous
Replies
1
Views
344
anonymous
Replies
3
Views
721
anonymous
Replies
6
Views
1K
anonymousPK
Replies
2
Views
539
anonymous
Replies
11
Views
2K
anonymous
Replies
26
Views
4K
anonymous
Replies
2
Views
564
anonymous
Replies
38
Views
7K
anonymous